301 related articles for article (PubMed ID: 22782402)
1. Lipid parameters and cardiovascular events in patients taking statins.
Martin SS; Jones SR
JAMA; 2012 Jul; 308(2):131-2; author reply 132-3. PubMed ID: 22782402
[No Abstract] [Full Text] [Related]
2. Lipid parameters and cardiovascular events in patients taking statins.
Brook RD; Rubenfire M
JAMA; 2012 Jul; 308(2):132; author reply 132-3. PubMed ID: 22782403
[No Abstract] [Full Text] [Related]
3. Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.
Sniderman AD; Thanassoulis G
Evid Based Med; 2013 Apr; 18(2):73-4. PubMed ID: 22893654
[No Abstract] [Full Text] [Related]
4. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
Boekholdt SM; Arsenault BJ; Mora S; Pedersen TR; LaRosa JC; Nestel PJ; Simes RJ; Durrington P; Hitman GA; Welch KM; DeMicco DA; Zwinderman AH; Clearfield MB; Downs JR; Tonkin AM; Colhoun HM; Gotto AM; Ridker PM; Kastelein JJ
JAMA; 2012 Mar; 307(12):1302-9. PubMed ID: 22453571
[TBL] [Abstract][Full Text] [Related]
5. PCSK9 Inhibitors and Cardiovascular Events.
Sabatine MS; Wasserman SM; Stein EA
N Engl J Med; 2015 Aug; 373(8):774-5. PubMed ID: 26295078
[No Abstract] [Full Text] [Related]
6. PCSK9 Inhibitors and Cardiovascular Events.
Goemann IM; Londero TM; Dora JM
N Engl J Med; 2015 Aug; 373(8):773-4. PubMed ID: 26287856
[No Abstract] [Full Text] [Related]
7. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.
Sniderman AD; Furberg CD; Keech A; Roeters van Lennep JE; Frohlich J; Jungner I; Walldius G
Lancet; 2003 Mar; 361(9359):777-80. PubMed ID: 12620753
[No Abstract] [Full Text] [Related]
8. PCSK9 inhibitors reduce cardiovascular events, preliminary data show.
Mayor S
BMJ; 2015 Mar; 350():h1508. PubMed ID: 25782694
[No Abstract] [Full Text] [Related]
9. Lowering LDL cholesterol is good, but how and in whom?
Stone NJ; Lloyd-Jones DM
N Engl J Med; 2015 Apr; 372(16):1564-5. PubMed ID: 25773740
[No Abstract] [Full Text] [Related]
10. [Statins remain the standard. New methods for lipid lowering therapy].
Aumiller J
MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281
[No Abstract] [Full Text] [Related]
11. [When statins alone are not enough. Putting a vice grip on cholesterol].
MMW Fortschr Med; 2002 Jun; 144(23):52-3. PubMed ID: 12119909
[No Abstract] [Full Text] [Related]
12. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
13. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
Barter P; Gotto AM; LaRosa JC; Maroni J; Szarek M; Grundy SM; Kastelein JJ; Bittner V; Fruchart JC;
N Engl J Med; 2007 Sep; 357(13):1301-10. PubMed ID: 17898099
[TBL] [Abstract][Full Text] [Related]
14. [Hyperlipidemia: decreasing lipid values and effects of statins].
Mathes P
Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
[No Abstract] [Full Text] [Related]
15. Dyslipidaemia. Assessing the efficacy and safety of evolocumab and alirocumab.
Huynh K
Nat Rev Cardiol; 2015 May; 12(5):261. PubMed ID: 25824512
[No Abstract] [Full Text] [Related]
16. PCSK9 Inhibitors and Cardiovascular Events.
Auer J; Berent R; Primus C
N Engl J Med; 2015 Aug; 373(8):773. PubMed ID: 26287855
[No Abstract] [Full Text] [Related]
17. PCSK9 Inhibitors and Cardiovascular Events.
Robinson JG; Kastelein JJ
N Engl J Med; 2015 Aug; 373(8):774. PubMed ID: 26287854
[No Abstract] [Full Text] [Related]
18. [Broader indication for treatment with statins; the 'heart protection study'].
Cleophas TJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2453; author reply 2453-4. PubMed ID: 12518529
[No Abstract] [Full Text] [Related]
19. Other therapies for reducing low-density lipoprotein cholesterol: medications in development.
Stein EA
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):99-119. PubMed ID: 19217514
[TBL] [Abstract][Full Text] [Related]
20. Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management.
Zárate A; Manuel-Apolinar L; Saucedo R; Hernández-Valencia M; Basurto L
Arch Med Res; 2016 Oct; 47(7):491-495. PubMed ID: 28262189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
